Zevra Therapeutics, Inc. (ZVRA) Total liabilities 2018–2025
Zevra Therapeutics, Inc. (ZVRA) total liabilities at each fiscal year-end, per SEC filings.
$130.1MFY2025 · since FY2018: $93.3M → $130.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $130.1M | -6.1% |
| FY2024 | $138.5M | +25.3% |
| FY2023 | $110.5M | +174.6% |
| FY2022 | $40.2M | +590.7% |
| FY2021 | $5.8M | -92.5% |
| FY2020 | $77.6M | -8.6% |
| FY2019 | $85.0M | -8.9% |
| FY2018 | $93.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice